small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (501)
  • Capabilities (82)
  • Experience (187)
  • Insights & News (5,190)
  • Other Results (126)

Professionals 501 results

T. Reed Stephens
T. Reed Stephens
Partner
  • Washington, DC
Email
+1 202-282-5795
vCard

Partner

  • Washington, DC
Charlie Papavizas
Charlie Papavizas
Partner
  • Washington, DC
Email
+1 202-282-5732
vCard

Partner

  • Washington, DC
Cari Stinebower
Cari Stinebower
Partner
  • Washington, DC
Email
+1 202-282-5788
vCard

Partner

  • Washington, DC
View All Professionals

Capabilities 82 results

Industry

Medical Devices

The medical device industry is currently undergoing monumental change—from supply chain challenges to disruptive technologies and economic fluctuations. To pave the way for a more accessible and innovative health care landscape—including advances in wearables, implants, diagnostics, mobility, drug delivery—the evolving and expansive medical device industry faces wide-ranging legal needs. Clients in this sector can tap the remarkable depth and breadth of our sector-focused and skilled attorneys in the U.S. and abroad. Our Health Care & Life Sciences Industry Group engages clients at all points in the product development life cycle to provide sound advice and practical solutions regardless of the client’s size or the complexity of their need. We help clients navigate today’s complex regulatory landscape, defend products and reputations in the face of high-profile product liability and mass tort claims, protect innovative intellectual property (IP), and leverage cross-border experience to advise on commercial transactions....Read more

Industry

Life Sciences

Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations....Read more

Practice Area

Government Program Fraud, False Claims Act & Qui Tam Litigation

Investigations and litigation involving alleged fraud against the government pose a significant and growing threat to organizations and individuals across all industries that engage directly or indirectly in business with federal, state, and/or local governments. The government makes aggressive use of its extensive criminal and civil investigatory powers to root out alleged fraud and abuse implicating government funds, including one of its most powerful civil enforcement tools—the federal False Claims Act (FCA)—and similar state false claims statutes....Read more

Experience 187 results

Experience

|

May 27, 2025

PicoCELA Inc. Closes $1.8 Public Offering

Experience

|

May 15, 2025

Winston Secures Federal Circuit Victory for Snap Axing Image-Presentation Patents on the Pleadings

Experience

|

May 9, 2025

An Am Law LOTW Shout Out-Worthy Gold Medal Victory In $Jenner

View All Experience

Insights & News 5,190 results

Sponsorship

|

August 5, 2025

Winston & Strawn Sponsors the Private Equity Chicago Forum

Winston & Strawn is proud to sponsor both the Private Markets Secondaries Meeting East and the 4th Private Equity Chicago Forum. This forum brings together senior executives from leading pension funds, endowments, foundations, consultants, family offices, and private equity firms to discuss the latest trends shaping private market allocations, fund selection, value creation, and strategic partnerships....Read more

Direct Sellers Update: Regulation, Law & Policy

|

August 4, 2025

|

9 Min Read

Robinson-Patman Act Enforcement in the Direct-Selling Industry: A Clearer Look

With renewed enforcement of the Robinson-Patman Act against illegal price discrimination looming, direct-selling companies should reassess their pricing models. The FTC has made clear that tiered wholesale pricing, which gives higher-ranked distributors more favorable terms than their lower-ranked counterparts, can create significant legal risks under antitrust laws.

Non-Fungible Insights: Blockchain Decrypted

|

July 31, 2025

|

4 Min Read

Preparing for Change: FCA Consultations Redefine the UK Digital Assets Regulatory Landscape

2025 is shaping up to be a pivotal year for the regulation of digital assets in the UK. As the European Union’s Markets in Crypto-Assets is reshaping the EU’s regulatory landscape by introducing a unified framework for crypto-asset service providers, the UK Financial Conduct Authority is advancing its own agenda, guided by its Cryptoasset Roadmap, to ensure regulatory clarity while supporting innovation. 

View All Insights & News

Other Results 126 results

Site Content

The Corporate Transparency Act
Task Force

Site Content

What Is The Jones Act?

The Jones Act, as used in the world of shipping is a law that reserves the transportation of goods between two points in the United States to qualified U.S.-flag vessels. This coastwise reservation law is named after its chief sponsor, Senator Wesley L. Jones. Similar laws apply to the transportation of passengers and reserve towing, dredging, and fishing in U.S. waters to qualified U.S.-flag vessels. Such vessels must be U.S. citizen-owned, U.S. citizen-crewed, U.S.-registered, and U.S.-built. Another law, also called the “Jones Act,” relates to merchant mariner injury recoveries....Read more

Site Content

What Is the Securities Act of 1933?

The Securities Act of 1933 (as amended, the “Securities Act”) was passed to ensure that investors have financial and other important information about securities that are being sold publicly. It also bans the use of fraud, deceit, and misrepresentation in the sales of securities. The Securities Act, which is also referred to as the “truth in securities” law, is part of a legislative effort to govern and oversee the securities industry....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising